Ad
related to: AVTX StockView Our Resources & Most Popular FAQs, We May Already Have An Answer For You. Pursue Your Financial Goals With Stocks, Options, ETFs, Mutual Funds, and More
Search results
- 10.85Add to watchlist-0.64 (-5.57%)At close: Fri. May 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open11.49High11.59Low10.35
- Mkt Cap11.22MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close11.4952 Wk. Low3.9552 Wk. High1,130.40
Top storiesOppenheimer Predicts Over 100% Rally for These 2 Healthcare StocksYahoo Finance · 1 week agoRelated stocks
Apr 26, 2024 · A high-level overview of Avalo Therapeutics, Inc. (AVTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
May 3, 2024 · Stock analysis for Avalo Therapeutics Inc (AVTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 19
5 days ago · Avalo Therapeutics' stock was trading at $9.10 on January 1st, 2024. Since then, AVTX stock has increased by 45.6% and is now trading at $13.25. View the best growth stocks for 2024 here.
- 540 Gaither Rd Ste 400, Rockville, Maryland 20850-6713
- ir@cerecor.com
- (410) 522-8707
- 19
3 days ago · Avalo Therapeutics - AVTX - Stock Price Today - Zacks. Avalo Therapeutics (AVTX) (Delayed Data from NSDQ) $11.73 USD. -1.52 (-11.47%) Updated May 8, 2024 04:00 PM ET. After-Market: $11.62...
People also ask
Should you buy Avalo Therapeutics (avtx) stock?
Where can I buy avtx stock?
Who owns avtx-800 series?
Is avtx trading at a 66% discount?
5 days ago · AVTX is a biotechnology company that develops targeted therapeutics for immunology and rare genetic diseases. It has a low price, a high uncertainty, and a negative profitability, according to Morningstar's quantitative ratings and valuation metrics.
May 3, 2024 · Avalo Therapeutics, Inc. (AVTX.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Avalo Therapeutics, Inc. | Nasdaq: AVTX | Nasdaq.
May 2, 2024 · 1Y. -97.6% Updated. 02 May, 2024. Data. Company Financials +. 1 Analyst. AVTX Stock Overview. Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. About the company. Rewards. Risk Analysis.
Ad
related to: AVTX StockView Our Resources & Most Popular FAQs, We May Already Have An Answer For You. Pursue Your Financial Goals With Stocks, Options, ETFs, Mutual Funds, and More